Lexaria Bioscience (LEXX) P/E Ratio
P/E Ratio as of Jul 2, 2025: -1.46
Average-1.63
Median-1.67
Minimum-1.80
Maximum-1.45
-1.46
Past Month+0.29 (16.57%)
The P/E ratio for Lexaria Bioscience (LEXX) is -1.46 as of Jul 2, 2025. This represents a decrease of -51.82% compared to its 12-month average P/E ratio of -3.03. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Lexaria Bioscience P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Lexaria Bioscience’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Lexaria Bioscience to industry peers.
Lexaria Bioscience P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Lexaria Bioscience’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Lexaria Bioscience to industry peers.
Lexaria Bioscience (LEXX) P/E Ratio Insights
See Lexaria Bioscience’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Lexaria Bioscience (LEXX)
Order type
Buy in
Order amount
Est. shares
0 shares
Lexaria Bioscience (LEXX) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jul 1, 2025 | $0.85 | -1.46 |
| Jun 2, 2025 | $0.9771 | -1.67 |
| May 1, 2025 | $1.23 | -2.11 |
| Apr 1, 2025 | $1.64 | -3.35 |
| Mar 3, 2025 | $1.28 | -2.62 |
| Feb 3, 2025 | $1.77 | -3.62 |
| Jan 2, 2025 | $2.30 | -5.03 |
Lexaria Bioscience (LEXX) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -1.46 | -68.19% |
| 2024 | -4.59 | +313.51% |
| 2023 | -1.11 | -46.63% |
| 2022 | -2.08 | -50.24% |
| 2021 | -4.18 | -26.28% |
| 2020 | -5.67 | — |
FAQs About Lexaria Bioscience (LEXX) P/E ratio
The latest P/E ratio of Lexaria Bioscience (LEXX) is -1.46, as of Jul 2, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Lexaria Bioscience’s last 12-month average P/E ratio is -3.03, compared to its current P/E ratio of -1.46. This reflects a decrease of -51.82%.
Lexaria Bioscience’s current P/E ratio of -1.46 is lower than its last 12-month average P/E of -3.03. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Lexaria Bioscience’s average P/E ratio over the last 3 years is -2.29. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Lexaria Bioscience’s average P/E ratio over the last 5 years is -3.52. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.